117 results
8-K
EX-1.1
ONCT
Oncternal Therapeutics Inc
17 Dec 21
Entry into a Material Definitive Agreement
5:17pm
Health Care Laws, except where the failure to be so conducted would not be expected, individually or in the aggregate, to result in a Material Adverse … or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”) except where
8-K
EX-1.1
ONCT
Oncternal Therapeutics Inc
28 May 21
Entry into a Material Definitive Agreement
5:03pm
to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in accordance with all applicable Health Care Laws … regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”) except where the failure to make
D
zegxw0 m1qj9
22 Dec 20
$6.47M in options / securities to be acquired, sold $6.47M, 4 investors
12:00am
8-K
EX-1.1
b9mbfps0sjf4 72cp1s4
11 Dec 20
Oncternal Therapeutics Announces $40.0 Million Bought Deal Offering
6:11am
D
ynropnii
24 Nov 20
$1.69M in options / securities to be acquired, sold $1.69M, 4 investors
4:25pm
8-K
EX-1.1
igq6 szf9v
19 Nov 20
Oncternal Therapeutics Announces $20.0 Million Bought Deal Offering
5:06pm
D
bxj5ywh
9 Sep 20
$382.55K in options / securities to be acquired, sold $382.55K, 4 investors
5:23pm
8-K
EX-1.1
jmnr e8i5mj0uk0
31 Aug 20
Oncternal Therapeutics Announces $3.5 Million Bought Deal Offering
4:33pm
D
s601vw
3 Aug 20
$3.46M in options / securities to be acquired, sold $3.46M, 12 investors
12:00am
D
vrm83mk m00svlia
3 Jun 20
$2.81M in options / securities to be acquired, sold $2.81M, 7 investors
4:28pm
8-K
EX-10.1
k2ztntq0 didii19
10 Jun 19
Entry into a Material Definitive Agreement
8:05am
424B3
y0ozxjbzxtfmdytgk
8 May 19
Prospectus supplement
12:00am